MedPath

Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis

Phase 3
Completed
Conditions
Blepharoptosis
Interventions
Other: Vehicle ophthalmic solution
Registration Number
NCT03565887
Lead Sponsor
RVL Pharmaceuticals, Inc.
Brief Summary

Phase 3 study to evaluate the safety and efficacy of treatment with RVL-1201 compared to placebo for treatment of blepharoptosis. Eligible subjects will be randomized to one of 2 treatment arms.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
164
Inclusion Criteria
  1. Male or Female 9 years of age or older
  2. Females must not be pregnant or planning to get pregnant and must use acceptable form of contraception
  3. Must be able to self-administer study medication
  4. Must be able to understand and sign an informed consent form. For minor subjects, the subject's parent or legal guardian must provide permission by signing an ICF on behalf of the subject and the subject should provide assent.
Exclusion Criteria
  1. Congenital ptosis
  2. Horner syndrome
  3. Myasthenia gravis
  4. Mechanical ptosis
  5. Previous ptosis surgery
  6. Resting heart rate outside the normal range
  7. Hypertension with resting diastolic blood pressure
  8. Pregnancy or lactation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Vehicle ophthalmic solutionVehicle ophthalmic solutionVehicle placebo ophthalmic solution
RVL-1201 ophthalmic solution 0.1%RVL-1201RVL-1201 (oxymetazoline hydrochloride) ophthalmic solution 0.1%
Primary Outcome Measures
NameTimeMethod
Mean Change in Number of Points Seen on the Leicester Peripheral Field Test (LPFT) in RVL-1201 Group vs. Vehicle GroupMean change from Baseline (Day 1, Hour 0) compared with Day 1, (Hour 6), and Day 14 (Hour 2)

LPFT Total Score is the number of points seen in the top 4 rows on the LPFT. Possible scores range from 0 (no points seen) to 35 (all points seen).

Secondary Outcome Measures
NameTimeMethod
Mean Change From Baseline in Marginal Reflex Distance (MRD) in the Study EyeBaseline Day 1 (Hour 0) and Day 1, Day 14, and Day 42

The Marginal Reflex Distance (MRD) is the distance from the center pupillary light reflex to the central margin of the upper eyelid. The MRD is measured from an external photograph using a handheld caliper and a millimeter ruler label placed on the subject's forehead as a measurement legend.

Trial Locations

Locations (35)

Hernando Eye Institute

🇺🇸

Brooksville, Florida, United States

Heart of America Eye

🇺🇸

Shawnee Mission, Kansas, United States

Kennar Eye Care

🇺🇸

Pittsburg, Kansas, United States

Michael Tran

🇺🇸

Westminster, California, United States

Danbury Eye Physicians

🇺🇸

Danbury, Connecticut, United States

Nashville vision Associates

🇺🇸

Nashville, Tennessee, United States

Barnet, Dulany Perkins

🇺🇸

Phoenix, Arizona, United States

Orange County Ophthalmology

🇺🇸

Garden Grove, California, United States

North Valley Eye

🇺🇸

Mission Hills, California, United States

Pendelton Eye Center

🇺🇸

Oceanside, California, United States

North Bay Eye Associates

🇺🇸

Petaluma, California, United States

Eye Research Foundation

🇺🇸

Newport Beach, California, United States

Shettle Eye Research

🇺🇸

Largo, Florida, United States

Sabal Eye Care

🇺🇸

Longwood, Florida, United States

East Florida Eye

🇺🇸

Stuart, Florida, United States

Maitland Vision Center

🇺🇸

Maitland, Florida, United States

Coastal Research Associates

🇺🇸

Roswell, Georgia, United States

Sarasota Retina Institute

🇺🇸

Sarasota, Florida, United States

Seidenberg Protzko Eye

🇺🇸

Havre De Grace, Maryland, United States

Mississippi Eye

🇺🇸

Ocean Springs, Mississippi, United States

Rochester Ophthalmological

🇺🇸

Rochester, New York, United States

Comprehensive Eye Care

🇺🇸

Washington, Missouri, United States

South Shore Eye

🇺🇸

Wantagh, New York, United States

Cornerstone Eye

🇺🇸

High Point, North Carolina, United States

CEENTA

🇺🇸

Charlotte, North Carolina, United States

Apex Eye

🇺🇸

Cincinnati, Ohio, United States

Quinn, Foster & Assoc.

🇺🇸

Athens, Ohio, United States

Abrams Eye Center

🇺🇸

Cleveland, Ohio, United States

R&R Research

🇺🇸

San Antonio, Texas, United States

Medical Center Ophthalmology Assocs - Keystone Research

🇺🇸

San Antonio, Texas, United States

Lake Travis Eye

🇺🇸

Lakeway, Texas, United States

Silverstein Eye

🇺🇸

Kansas City, Missouri, United States

Round Rock Eye

🇺🇸

Austin, Texas, United States

Texan Eye / Keystone

🇺🇸

Austin, Texas, United States

West Coast Eye

🇺🇸

Lecanto, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath